US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 24.660
  • +0.760+3.18%
Close May 10 16:00 ET
  • 24.500
  • -0.160-0.65%
Post 16:59 ET
203.54MMarket Cap-64386P/E (TTM)

About CervoMed Company

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.

Company Profile

SymbolCRVO
Company NameCervoMed
Listing DateNov 9, 2016
Founded1995
CEODr. John J. Alam, M.D.
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address20 Park Plaza,Suite 424
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02216
Phone1-617-744-4400
Websitehttp://www.cervomed.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John J. Alam, M.D.
  • Chief Executive Officer, President and Director
  • 815.16K
  • Dr. J. William Tanner, PhD
  • Chief Financial Officer
  • --
  • Dr. Robert Joseph Cobuzzi, Jr,PhD
  • Chief Operating Officer and Director
  • 703.12K
  • William R. Elder
  • General Counsel, Corporate Secretary and Acting Principal Financial Officer
  • 468.35K
  • Kelly Blackburn
  • Senior Vice President, Clinical Development
  • 465.74K
  • Dr. Joshua S. Boger,PhD
  • Chairman of the Board
  • --
  • Dr. Sylvie Gregoire,Pharm.D.
  • Director
  • 376.94K
  • Frank Zavrl
  • Independent Director
  • 47.76K
  • Jeffrey V. Poulton
  • Independent Director
  • 47.20K
  • Jane H. Hollingsworth
  • Independent Director
  • 82.91K
  • Dr. Marwan Noel Sabbagh, M.D.
  • Independent Director
  • 41.15K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg